33.93 USD
↘ 0.87 (2.50%)AT CLOSE (11:59 AM EDT)
Viking Therapeutics, Inc
VKTXNASDAQ • USD
34.15
↗ 0.17 (0.49%)
POST MARKET (AS OF 04:52 PM EDT)
Post Market
AS OF 04:52 PM EDT
34.15
↗ 0.17 (0.49%)
Market: OPEN
Open?$34.50
High?$35.24
Low?$33.77
Prev. Close?$34.80
Volume?2.4M
Avg. Volume?2.5M
VWAP?$34.53
Rel. Volume?0.94x
Bid / Ask
Bid?$32.13 × 100
Ask?$36.09 × 100
Spread?$3.96
Midpoint?$34.11
Valuation & Ratios
Market Cap?4.0B
Shares Out?115.9M
Float?103.1M
Float %?91.2%
P/E Ratio?N/A
P/B Ratio?6.29
EPS?-$3.11
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?9.33Strong
Quick Ratio?9.33Strong
Cash Ratio?2.16Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?6.29FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-9.8CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-56.3%WEAK▾
ROA?-50.2%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$3.9B
Related Companies
Loading...
News
Profile
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Employees
53
Market Cap
4.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-04-29
Address
9920 PACIFIC HEIGHTS BLVD, SUITE 350
SAN DIEGO, CA 92121
Phone: 858-704-4660
SAN DIEGO, CA 92121
Phone: 858-704-4660